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ORIGINAL ARTICLE  
 
EVALUATION OF QUALITY OF LIFE OF ADULT CANCER 
PATIENTS ATTENDING TIKUR ANBESSA SPECIALIZED 







BACKGROUND: Little is known about the quality of life of cancer patients in the Ethiopian context. 
This study evaluated quality of life of cancer patients in Ethiopia. 
METHODS: A cross-sectional study was conducted in Addis Ababa University Tikur Anbessa 
Specialized Referral Hospital Addis Ababa, Ethiopia (TASRH) from March to May 2013.   A total of 388 
cancer patients were included. Translated in to Amharic, the European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC QOL C-30) was used to measure Quality of 
life (QoL). The data was analyzed with SPSS Version 17.0.  
RESULTS: Among the participants, 251(64.7%) were men and 138(35.6%) were below the age of 40 
years. Large proportion of patients were diagnosed with breast cancer, 114(29.4%), and cervical cancer, 
102(26.3%), and the clinical stages during the beginning of therapy were at stage II a 133(34.3%). The 
mean of global health status/QoL was 57.28 (SD= 25.28). Quality of life was found to be associated with 
some functional scales as role functioning, P≤0.001, social function, P=0.00, and symptom scales as 
pain, P=0.00, loss of appetite, P=0.004, and financial impact, P=0.02, but no associations were noted in 
relation to socio demographic characteristics.  
CONCLUSION: Quality of life assessments should be included in patient treatment protocols to improve 
their quality of life since being a cancer patient may be associated with a high level of impairment in 
different aspects of life.  
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INTRODUCTION   
 
Cancer is predicted to be an increasingly 
important cause of morbidity and mortality in the 
next few decades, in all regions of the world (1). 
Within the forecasted changes in population 
demographics in the next two decades, even if 
current global cancer rates remain unchanged, the 
estimated incidence of 12.7 million new cancer 
cases in 2008 (1) will rise to 21.4 million by 
2030(2).  
While cancer diagnosis has become more 
prevalent, it is no longer considered to be a death 
sentence, but rather a disease that patients must 
manage and live with. Numerous studies have 
shown that depression, anxiety, stress and poor 
quality of life are often psychological 
consequences of living with cancer, and cancer 
patients face the double challenge of learning to 
manage the physical as well as psychological 
effects of cancer. Moreover, previous studies 
suggest that depression and poor quality of life 
have been associated with 5 year survival rates as 
well as increased mortality due to cancer (3). 
Cancer is known to reduce quality of life, and 
it has been evident that decreased QoL has a 
negative effect not only on physiological 
symptoms but also on the psychological functioning 
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of the individual (3, 4). It has also been suggested 
that determining QoL in cancer patients could 
contribute to improved treatment and could be as 
prognostic as medical factors (3)
 
and as the 
survival benefit that a pharmacological treatment 
may provide (5). In addition, QoL in cancer 
patients is an important outcome and is now 
considered a significant end-point in cancer 
clinical trials, as proposed by the World Health 
Organization (WHO) (3). 
One study (6) put forward that patients with 
lower coping capacity reported a higher 
prevalence of cancer symptoms, experienced 
higher levels of distress and experience 
encountered worse perceived health, which in 
turn decreased the quality of their life. Another 
study (7) found out that, as survival rates for 
cancer have improved, quality of life issues have 
increased in importance. The researchers 
examined how patient perceptions of the side 
effects of chemotherapy changed from 
predominantly physical concerns to psychosocial 
concerns. Patients undergoing chemotherapy were 
asked to select side effects from physical and non-
physical symptoms, and rank them according to 
how ‘troublesome’ they were. Despite an 
extensive list of physical side effects, four of the 
top six were non-physical (affects my family or 
partner, loss of hair, constant tiredness, affects my 
work and/or home duties, affects my social 
activities, loss of sexual feeling in order of 
severity) (7). 
Ethiopia has a population of more than 84 
million people, and is expected to become the 
ninth most populous country in the world by 
2050(8). The growing population coupled with 
lifestyle changes will mean an increasing burden 
of cancer. However, oncology services are wholly 
inadequate; no cancer registry exists, and only one 
cancer centre, with a handful of doctors and 
nurses, struggles to serve the entire country (8). 
In Ethiopian, although few researches have 
conducted to evaluate QoL in some diseases (9), 
no research has been conducted to evaluate QoL in 
cancer patients. Considering the increasing 
prevalence of cancer and its destructive effects on 
QoL and low local reports pertaining to QoL of 
cancer patients, this study aimed to evaluate QoL 
of adult cancer patients. Results of this 
investigation are believed to provide a foundation 
for interventions to improve QoL among patients 




The study setting and samples: The study was 
conducted at TASRH from March to May 
2013.TASRH was chosen since it is currently the 
only hospital which provides cancer therapy. 
Sample size was determined using single 
population proportion formula. During the study, 
those patients who have been diagnosed with any 
type of cancer, 18 years and older, had at least 6 
months duration of cancer diagnosis, able to 
understand Amharic and had no other serious 
debilitating co-morbidity were included by 
random selection.  
 
Data collection instrument: Data on QoL was 
collected by trained nurses through face-to-face 
interview using the Amharic version of  EORTC 
QLQ-C30 (10).The EORTC QLQ-C30 is a 30-
item questionnaire composed of 5 multi-item 
functional subscales: physical, role, emotional, 
social and cognitive functioning; three multi-item 
symptom scales measuring fatigue, pain, and 
emesis; a global health status subscale; and six 
single items to assess financial impact and 
symptoms such as dyspnea, sleep disturbance, 
appetite, diarrhea, and constipation. Variables 
related to socio-demography and clinical 
information as cancer type, time since diagnosis, 
type of therapy and number of chemotherapy 
sessions were extracted from charts in the 
oncology unit. 
Data management and analysis: Data were 
cleaned, coded, and entered into Microsoft Office 
Excel 2007, Epi-info version 3.5.1 software and 
then exported to SPSS Version 17.0 for analysis. 
Domain scores in EORTC QLQ-C30 which 
measures a functional scale and global health 
status were recorded so that higher scores 
reflected better QoL and a high score for a 
symptom scale represented a high level problem. 
The raw scores were transformed to scores 
ranging from 0 to 100. The use of these 
transformed scores has several advantages (10). 
Transformed scores may be difficult to interpret; 
however, there are a number of ways to ease the 
interpretation of QLQ-C30 results. It is possible to 
 
 





report the raw scores in addition to the 
transformed scores. For example, it may be 
clinically relevant to know the proportion of 
patients that are ‘Quite a bit’ or ‘Very much’ 
constipated, but this study presents transformed 
results to comply with the word limit of this 
journal. 
Linear transformation to 0-100 to obtain the 
score S, has been done by using the following 
formula (10). 
Raw score- RS= (I1+I2+….In)/n 
Linear transformation-Apply the linear 




There are no existing data for the EORTC QLQ-
C30 scales to indicate the threshold scores that are 
likely to mean significant impairment. Therefore, 
in this study, after transformation of each domain 
was dichotomized into “Affected at any degree” 
and “Not affected at all” in which a score below 
75 for functional and global health (QoL) scales 
are used as affected and scores above 25 have 
been used as affected for symptom scales.  
Bivariate analysis was performed to assess 
the predictors of QoL. Multivariable logistic 
regression analysis was also performed to assess 
the association between the dependent variables 
and various explanatory variables.  P-value less 
than or equal to 0.05 was taken as cut of value to 
be significant. Odds ratio and 95% confidence 
intervals were also constructed.  
 
Ethical considerations: Ethical clearance was 
obtained from the Ethical Committee of Addis 
Ababa University. Permission letters were 
received from EORTC research group to use 
questionnaire and TASRH to collect data and use 
clinical records. 
      Study participants were informed about the 
objective of the study before data collection and 
asked for consent.  
 
Quality assurance of the study: The English 
version of the questionnaire was translated into 
Amharic and back translated into English to check 
its consistency. The data collectors as well as the 
supervisor were oriented on the overall data 
collection procedure. Five percent of the 
questionnaire was pre-tested to check acceptability 





Socio demographic characteristics and their 
association with QoL: Of 422 eligible 
respondents, 34(8.05%) refused to participate, and 
were excluded from the study (response rate = 
91.95 %). Among the participants, 251(64.7%) 
were women and 138(35.6%) were below the age 
of 40 years with 172(44.3%) of respondents 
earning <300 Birr per month. The majority of the 
respondents attended some level of formal 
education 239(61.6 %), 256(66.0 %) were 
Orthodox Christians and 254(65.5%) were married 
followed by 16.8% singles. 
For all socio-demographic variables after 
adjustment, no associations were noted. Table 1 
shows associations between socio- demographic 

















Table 1: Associations between Socio-demographic variables and quality of life of cancer patients at 
TASRH, Addis Ababa Ethiopia, March -May 2013 
 





OR(95% CI) P 
Age n=388 
 
<40  120(34.5) 18(45.0)   
40-49  79(22.7) 7(17.5)   
50-59  82(23.6) 9(22.5)   
60-69  53(15.2) 6(15)   
70+  14(4.0) 0   
Sex Male 117(33.6) 20(50) 1.90(0.69,5.24) 0.22 






<300 160(46.0) 12(30.0) 0.90(0.09,9.38) 0.93 
300-600 22(6.3) 5(12.5) 1.76(0.12,25.6) 0.68 
601-1200 84(24.1) 7(17.5) 2.05(0.20,20.4) 0.54 
1201-2000 36(10.3) 8(20.0) 2.83(0.27,29.6) 0.39 
2001-3200 19(5.5) 6(15.0) 6.80(0.57,80.8) 0.13 
>3200 27(7.8) 2(5.0)   
Occupation  Housewife 110(31.6) 9(22.5)   
Government employee 18(5.2) 4(10.0)   
Private  63(18.1) 13(32.5)   
Farmer 54(15.5) 8(20.0)   
Jobless 57(16.4) 3(7.5)   
Student 34(9.8) 1(2.5)   
Pension  12(3.4) 2(5.0)   
Educational status 
n=388  
Formal Education 120(34.5) 6(15.0)   
Illiterate  207(59.5) 32(80.0)   
Informal Education 21(6.0) 2(5.0)   
Marital status n=388 Married  54(15.5) 11(27.5)   
Single 231(66.4) 23(57.50   
Widowed  13(3.7) 2(5.0)   




Orthodox  226(64.9) 30(75.0)   
Muslim 41(11.8) 7(17.5)   
Protestant 4(1.1) 0   
Catholic 68(19.5) 3(7.5)   
Others * 9(2.6) 0   
* Wake feta, Adventist and Jehovah Witness 
 
Clinical characteristics and their association 
with QoL: The most prevalent types of cancer 
were Breast cancer 114(29.4%) and Cervical 
cancer 102(26.3%), and the clinical stages during 
therapy were at stage IIa 133(34.3%) with 4(1.0%) 
of unknown status at the time of diagnosis. Only 
few of the respondents, 66(17.0%), complain co-
morbidities like Diabetes, Hypertension, HIV and 
Kidney problems. 
In relation to clinical information, those in the 
second cycle of chemotherapy (P=0.04) showed 
significant association with QoL, but no 
associations were noted with type of therapy, time 
since diagnosis, stage at diagnosis and presence of 
other co-morbidities. Table 2 shows associations 
between clinical variables and QoL. 
 





Table 2: Associations between clinical variables and quality of life of cancer patients at TASRH, Addis 
Ababa Ethiopia, March-May 2013 
 
 
Variable Quality of Life Adjusted  




6 month- 1 year 160(46.0) 23(57.5)   
1- 2 year 72(20.7) 7(17.5)   
2-3 year 42(12.1) 3(7.5)   
3- 4 year 26(7.5) 3(7.5)   
4- 5 year 16(4.6) 0   
5- 10  year 20(5.7) 2(5.0)   
10- 15 year 2(0.6) 1(2.5)   





Stage I 36(10.3) 8(20.0)   
Stage II a 119(34.2) 14(35.0)   
Stage II b 18(5.2) 0   
Stage III 77(22.1) 8(20.0)   
Stage IV   53(15.2) 5(12.5)   
Recurrent   41(11.8) 5(12.5)   




Surgery  25(7.2) 3(7.5)   
Chemotherapy  46(13.2) 6(15.0)   
Radiation therapy 79(22.7) 7(17.5)   
Surgery  and 
Chemotherapy 
79(22.7) 12(30.0)   
Surgery  and 
Radiation therapy 
25(7.2) 5(12.2)   
Chemotherapy and 
Radiation therapy 




51(14.7) 3(7.5)   
Not started 18(5.2) 2(5.0)   
 
 
Number of  
CT sessions 
for those on 
Chemotherapy 
n=225 
First  55(27.1) 5(22.7) 0.13(0.01,1.32) 0.08 
Second 33(16.3) 2(9.1) 0.07(0.01,0.88) 0.04* 
Third  19(9.4) 0 0.00 0.10 
Fourth  17(8.4) 1(4.5) 0.13(0.01,2.30) 0.16 
Fifth  10(4.9) 5(22.7) 0.68(0.07,7.06) 0.75 
Sixth  65(32.0) 7(31.8) 0.17(0.02,1.67) 0.13 
Seventh  1(0.5) 0 0.00 1.00 
Eighth  3(1.5) 2(9.1) 1.00  
Co morbidity  
n=388 
Yes  63(18.1) 3(7.5)   









Quality of life and functional scales: Significant 
association was noted between role functioning 
(P=0.01, AOR=0.38(0.19,0.76 95%CI))like 
limited in doing work or other daily activities and 
pursuing hobbies or other leisure time activities. 
Association was also noted with social functioning 
(P≤0.001,AOR=0.26 (0.15-0.45 95% CI) in which  
physical conditions or medical treatment 
interfered with family life and social activities but 
no associations were observed between physical, 
emotional and cognitive functioning.  
 
Table 3: Associations between functional scales and quality of life of cancer patients at TASRH, Addis 
Ababa Ethiopia, March-May 2013 
 
 
Variables  Quality of Life Adjusted OR 
Not  affected (%) Affected (%) AOR(95% CI) P 
Physical 
Functioning 
Not affected 55(63.2) 106(35.2) 0.72(0.36,1.44) 0.34 
Affected 32(36.8) 195(64.8) 1.00  
Role 
Functioning 
Not affected 59(67.8) 101(33.6) 0.49(0.23,1.0) ≤0.01* 
Affected 28(32.2) 200(66.4) 1.00  
Emotional   
Functioning  
Not affected 34(39.1) 53(60.9)   
Affected 101(33.6) 200(66.4)   
Cognitive 
functioning  
Not affected 66(75.9) 21(24.1)   
Affected 198(65.8) 103(34.2)   
Social 
functioning 
Not affected 41(47.1) 46(52.9) 0.26(0.14,0.45) ≤0.001* 
Affected 46(15.3) 255(84.7) 1.00  
*Significant association 
Quality of life and symptom scales Symptom 
scales like dyspnea and diarrhea showed no 
association at all, but pain (P≤0.001), appetite loss 
(P=0.004) and financial difficulties (P=0.02) were 
shown to be associated with QoL. Symptom scales 
like fatigue, nausea and vomiting, sleep 
disturbance and constipation showed no 






















Table 4: Associations between symptom scales and quality of life of cancer patients TASRH, Addis Ababa 
Ethiopia, March-May 2013 
 
Variables  Quality of Life Adjusted OR 
Not affected (%) Affected (%) AOR(95% CI) P 
Fatigue  
 
No 29(33.3) 58(66.7) 0.86(0.44,1.67) 0.66 
Yes 43(14.3) 258(85.7)   
Nausea & 
vomiting 
No 62(71.3) 25(28.7) 0.97(0.52,1.78) 0.92 
Yes 154(51.2) 147(48.8)   
Pain No 55(63.2) 32(36.8) 0.28(0.15,0.49) 0.00* 
Yes 75(24.9) 226(75.1)   
Dyspnea     No 59(67.8) 28(32.2)   
Yes 176(58.5) 125(41.5)   
Insomnia No 52(59.8) 35(40.2) 1.17(0.65,2.11) 0.60 
Yes 136(45.2) 165(54.8)   
Appetite 
loss 
No 51(58.6) 36(41.4) 0.42(0.24,0.76) 0.004* 
Yes 85(28.2) 216(71.8)   
Constipation No 62(71.3) 25(28.7) 0.61(0.34,1.09) 0.06 
Yes 146(48.5) 155(51.5)   
Diarrhea No 75(86.2) 12(13.8)   
Yes 232(77.1) 69(22.9)   
Financial 
Impact 
No 11(12.6) 76(87.4) 0.26(0.09,0.77) 0.02* 




There has been little quantitative and qualitative 
assessment of QoL of cancer patients in African 
context including Ethiopia. Assessing QoL 
dimensions in which cancer patients are lacking is 
of a remarkable impact in cancer care. This study 
has tried to address this issue. It has analyzed self-
reported QoL of cancer patients in relation to 
different clinical and socio demographic factors 
and functional and symptom scales using EORTC-
C30 core questionnaire. 
The EORTC QLQ-C30 is an integrated 
system for assessing the QoL of cancer patients 
participating in clinical trials and other types of 
research in which patient-reported outcomes are 
collected.  The EORTC QLQ-C30 is designed for 
use with a wide range of cancer patient 
populations. The psychometric properties of the 
questionnaire were tested, and it was found to 
possess the required standards such as validity, 
reliability and sensitivity (11).  The questionnaire 
was initially tested in a population of lung cancer 
patients and subsequently in a variety of cancer 
patient groups. The Amharic translation was used 
after repeated forward and backward translations 
of the questionnaire. 
This study like a study done in Iran Tehran 
hospital (5) showed no correlation between the 
QoL and variables such as age, sex, marital status, 
duration of disease, economic conditions, 
occupational function and patients’ educational 





level (literate or illiterate) (5). Similarly a study 
done in Athens Hospital, Greece (12) showed 
gender, marital status, and educational level had 
no influence on the subjective health condition of 
the patients. Similarly another study in Iran 
showed none of the demographic variables (age, 
education, marital status, income) were 
significantly related to QoL(13). 
As opposed to these studies, different studies 
(14, 15, 16, 17) showed associations with socio-
demographic differences like gender, educational 
level, and marital status with QoL. A study 
conducted at the outpatient and inpatient 
Oncology Clinics of the Lütfi Kirdar Teaching and 
Research Hospital in Istanbul, Turkey (14) 
showed that socio-demographic factors rather than 
cancer-related factors could contribute to poorer 
QoL in which age and educational level were 
associated with particular domains of QoL. 
Elderly subjects reported lower QoL in all sub-
dimensions (14).Significant differences existed in 
subscales of QoL and total QoL among the 
patients who had different educational level. This 
difference may be related with use of different 
assessment tools in which some use 
Multidimensional Quality of Life Scale-Cancer 2 
(MQOLS-CA2)(14) and Euro Quality of life five 
individual-level dimensions (EQ-5D)(15,16,17),  
maybe due to difference in patient population or 
type of cancer.  
In this study, among clinical parameters, only 
cycle of chemotherapy showed significant 
association and those in the second cycle of 
chemotherapy were more likely to have affected 
QoL, but no association was noted between QoL 
and time since diagnosis, type of therapy, stage 
during diagnosis and presence of other co-
morbidities. This finding is similar with a study 
conducted in Shahid Ghazi Tabatabaei University 
Hospital (18) which showed no significant 
correlation between QoL and the time of cancer 
diagnosis. Similarly study done in Iran (14) 
showed duration of the disease and type of cancer, 
presence of metastasis, and type of treatment had 
no effect on QoL which is similar with this study. 
Cancer patients who started chemotherapy and 
were in the second cycle of chemotherapy 
(P=0.04) showed association with affected QoL 
which has some similarity with other studies that 
showed significant difference between the level of 
QoL in patients with < 2 CT cycles and/or with 3-
5 cycles (p< 0.001)(5,13). 
Each of the 15 scale scores of the EORTC 
QLQ-C30 were analyzed and different dimensions 
of these scores obtained lower scores. These scale 
scores were calculated by averaging items within 
scales and transforming average scores linearly. 
All of the scales ranged in score from 0 to 100. A 
high score for a functional scale represents a 
high/healthy level of functioning whereas a high 
score for a symptom scale or item represents a 
high level of problems and all interpretations were 
done based on this assumption.  
The QoL results from this study indicate 
lower role, emotional and social functioning than 
physical functioning. Role functioning had a mean 
of 43.36(SD=43.32), emotional functioning had a 
mean of 45.88 (SD=42.28), social functioning had 
a mean of 39.69(SD=39.69) and physical 
functioning had a mean of 62.71 (SD=34.86). The 
mean of global health status was 57.28 (SD= 
25.28) which is relatively similar with EORTC 
(10), lower than the study in Sweden (6) and better 
than a study in Tanzania (19) with means of 61.3, 
63.69 and 49.5, respectively. 
According to the results of this study, all 
dimensions of functional scales except for 
cognitive function were shown to be lower than 
the standard values for comparison (10), and 
studies done in Sweden (6) and Iran (20). This 
may be related to the differences in sample size 
and sample population in which the comparison 
study (10) had been conducted in a large number 
of populations (23,553 people) in a wide variety of 
patients (patients from 49 countries). However, in 
comparison with a study done in Tanzania (19), 
most of the findings were found to be closer 
except for emotional functioning in which 
Tanzanian patients were affected less (Mean of 
71.8 and SD=28.5 vs Mean of 45.88 and 
SD=42.28) and  more affected in cognitive 
function. In addition, Tanzanian patients (19) were 
affected more in physical functioning than patients 
in the present study.  
The findings from this study concerning 
symptom scales were lower in most aspects from 
other studies (6, 10, 19, 20), except for pain and 
insomnia in which Tanzanians (19) suffer more 
pain and sleep problems than the subjects of this 
study. On the other hand, the Iranians (20) 





complained of more nausea and vomiting and 
diarrhea. 
In this study, financial difficulties and fatigue 
had the highest scores, and diarrhea had the lowest 
scores. Financial difficulties had a mean of 
88.42(SD=21.06), fatigue had a mean of 65.15 
(SD =35.23) and the mean of diarrhea was 15.44 
(SD =32.90). As opposed to the findings of this 
study in which financial impact is of the most 
affected, a study done in Sweden (6) showed 
financial difficulties as least affected with a mean 
6.54 (SD= 17.31). This difference may be related 
to differences in economic status of Ethiopia and 
Sweden.   
In general, disparities between results of this 
study and other previous studies (6, 10, 19, 20) 
can be related to the age of the subjects, the size of 
the sample, difference in recruited group of 
patients with different types and stages of cancer, 
and cultural factors.  
Cancer patients in Ethiopia who visited 
TASRH report different effects related with 
cancer. Those survey patients report a low level of 
quality of life, a high level of symptoms, and a 
large number of unmet needs like emotional 
support and respected care, financial support and 
pain relief. Access to the health care specifically 
to a chemotherapy and radio therapy services was 
also raised.  
Being a cancer patient was associated with a 
high level of impairment in different aspects of 
life. Therefore it needs to be considered that QoL 
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